473 related articles for article (PubMed ID: 11740690)
1. Anticoagulant factor concentrates in disseminated intravascular coagulation: rationale for use and clinical experience.
de Jonge E; van der Poll T; Kesecioglu J; Levi M
Semin Thromb Hemost; 2001 Dec; 27(6):667-74. PubMed ID: 11740690
[TBL] [Abstract][Full Text] [Related]
2. Pathogenesis and treatment of disseminated intravascular coagulation in the septic patient.
Levi M
J Crit Care; 2001 Dec; 16(4):167-77. PubMed ID: 11815902
[TBL] [Abstract][Full Text] [Related]
3. Disseminated Intravascular Coagulation: An Update on Pathogenesis, Diagnosis, and Therapeutic Strategies.
Papageorgiou C; Jourdi G; Adjambri E; Walborn A; Patel P; Fareed J; Elalamy I; Hoppensteadt D; Gerotziafas GT
Clin Appl Thromb Hemost; 2018 Dec; 24(9_suppl):8S-28S. PubMed ID: 30296833
[TBL] [Abstract][Full Text] [Related]
4. [Clinical trials for severe sepsis/DIC].
Kushimoto S
Rinsho Byori; 2011 Feb; Suppl 147():85-94. PubMed ID: 21761754
[No Abstract] [Full Text] [Related]
5. Microthrombosis in sepsis.
Vallet B
Minerva Anestesiol; 2001 Apr; 67(4):298-301. PubMed ID: 11376528
[TBL] [Abstract][Full Text] [Related]
6. [Coagulation tests in septic surgical patients].
Oberhofer D; Kucisec-Tepes N; Skok J; Vucić N; Cala K
Acta Med Croatica; 2004; 58(5):389-94. PubMed ID: 15756805
[TBL] [Abstract][Full Text] [Related]
7. Tissue factor pathway inhibitor and P-selectin as markers of sepsis-induced non-overt disseminated intravascular coagulopathy.
Mosad E; Elsayh KI; Eltayeb AA
Clin Appl Thromb Hemost; 2011 Feb; 17(1):80-7. PubMed ID: 19689998
[TBL] [Abstract][Full Text] [Related]
8. Plasma tissue factor and tissue factor pathway inhibitor levels in patients with disseminated intravascular coagulation.
Shimura M; Wada H; Wakita Y; Nakase T; Hiyoyama K; Nagaya S; Mori Y; Shiku H
Am J Hematol; 1996 Jul; 52(3):165-70. PubMed ID: 8756081
[TBL] [Abstract][Full Text] [Related]
9. [Coagulation disorders in sepsis].
Heslet L; Nielsen JD
Ugeskr Laeger; 2000 May; 162(20):2849-51. PubMed ID: 10860418
[No Abstract] [Full Text] [Related]
10. Effects of anticoagulant strategies on activation of inflammation and coagulation.
Feistritzer C; Wiedermann CJ
Expert Opin Biol Ther; 2007 Jun; 7(6):855-70. PubMed ID: 17555371
[TBL] [Abstract][Full Text] [Related]
11. The effect of antithrombin on the systemic inflammatory response in disseminated intravascular coagulation.
Nielsen JD
Blood Coagul Fibrinolysis; 1998 Nov; 9 Suppl 3():S11-5. PubMed ID: 10102494
[TBL] [Abstract][Full Text] [Related]
12. Role of coagulation inhibitors in inflammation.
Esmon CT
Thromb Haemost; 2001 Jul; 86(1):51-6. PubMed ID: 11487041
[TBL] [Abstract][Full Text] [Related]
13. Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology.
Levi M; Toh CH; Thachil J; Watson HG
Br J Haematol; 2009 Apr; 145(1):24-33. PubMed ID: 19222477
[TBL] [Abstract][Full Text] [Related]
14. The effect of two-domain tissue factor pathway inhibitor on endotoxin-induced disseminated intravascular coagulation in rabbits.
Bregengård C; Nordfang O; Wildgoose P; Svendsen O; Hedner U; Diness V
Blood Coagul Fibrinolysis; 1993 Oct; 4(5):699-706. PubMed ID: 8292719
[TBL] [Abstract][Full Text] [Related]
15. Monoclonal antibody specific for tissue factor pathway inhibitor-factor Xa complex: its characterization and application to plasmas from patients with disseminated intravascular coagulation and pre-disseminated intravascular coagulation.
Ohkura N; Soe G; Kohno I; Kumeda K; Wada H; Kamikubo Y; Shiku H; Kato H
Blood Coagul Fibrinolysis; 1999 Sep; 10(6):309-19. PubMed ID: 10493212
[TBL] [Abstract][Full Text] [Related]
16. Coagulopathy of sepsis.
Dempfle CE
Thromb Haemost; 2004 Feb; 91(2):213-24. PubMed ID: 14961146
[TBL] [Abstract][Full Text] [Related]
17. Fibrinolysis in disseminated intravascular coagulation.
Hack CE
Semin Thromb Hemost; 2001 Dec; 27(6):633-8. PubMed ID: 11740686
[TBL] [Abstract][Full Text] [Related]
18. Infection and inflammation and the coagulation system.
Levi M; Keller TT; van Gorp E; ten Cate H
Cardiovasc Res; 2003 Oct; 60(1):26-39. PubMed ID: 14522404
[TBL] [Abstract][Full Text] [Related]
19. Rationale for restoration of physiological anticoagulant pathways in patients with sepsis and disseminated intravascular coagulation.
Levi M; de Jonge E; van der Poll T
Crit Care Med; 2001 Jul; 29(7 Suppl):S90-4. PubMed ID: 11445740
[TBL] [Abstract][Full Text] [Related]
20. [Therapeutic strategy of newly developing medicines for disseminated intravascular coagulation--activated protein C and thrombomodulin].
Maruyama I
Nihon Rinsho; 1993 Jan; 51(1):99-106. PubMed ID: 8381887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
